We previously reported a large-scale unbiased drug sensitivity screen in an extensive cancer cell line panel, and identified hypersensitivity of Ewing’s sarcoma cells (EWSCs) to distinct PARP inhibitor (PARPi) chemotypes [7]. Here, PARP1 is linked to cancer.